This is the last article you can read this month
You can read more article this month
You can read more articles this month
Sorry your limit is up for this month
Reset on:
Please help support the Morning Star by subscribing here
GLAXOSMITHKLINE said today that it would pay $105 million (£63m) to dozens of US states to settle allegations that it unlawfully marketed drugs.
Californian Attorney General Kamala Harris said that the London-based pharmaceutical giant had also accepted several restrictions.
It will be barred from paying doctors to promote its products, providing financial incentives to encourage salespeople to market drugs for unapproved uses, marketing drugs using results from inadequate studies and making unapproved claims.
California was among 44 states of which the attorneys general had filed identical lawsuits in local courts.
It will receive more than $7m (£4.1m) — the largest single payout — after the deal is approved in the San Diego County Superior Court.
The state lawsuits claimed that GlaxoSmithKline violated state consumer protection laws by misrepresenting the uses and qualities of the drugs and marketing them for purposes unapproved by the federal-level Food and Drug Administration.
GlaxoSmithKline did not acknowledge any wrongdoing under the settlement.
